Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-13-000018)

Filing Details

Accession Number:: 0001415889-13-000018
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-03 19:21:46
Reporting Period:: 2012-12-28

Filing Date:: 2013-01-03
Accepted Time:: 2013-01-03 19:21:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374328	Bond Laboratories Inc.	BNLB.OB	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1497702	S Michael Abrams	4509 South 143Rd Street Suite 1 Omaha NE 68137	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-28	1,050,565	$0.00	1,795,565	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options	$0.09	2012-04-13	2017-04-13	100,000	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-04-13	100,000	100,000	Direct

Footnotes

The Reporting Person acquired the shares of Issuer's common stock for aggregate consideration of $12,500 in a privately negotiated transaction.